Atlas Trials

Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy

Clinical trial NCT03936127 · UNKNOWN

Trial details

NCT number
NCT03936127
Sponsor
Dr. Nicola Schieda
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2022-10-11
Primary completion
2024-12-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.